Loss-of-function mutations in NIS are very rare in thyroid cancer, and the reduced iodine transport exhibited by most thyroid cancer cells appears to be related to silencing or post-translational changes prohibiting the essential plasma membrane localisation of NIS (12, 13, 14). Here, SLC5A5 is linked to thyroid gland carcinoma.